DJIA 16,399.67 19.26 0.12%
NASDAQ 4,316.07 57.64 1.35%
S&P 500 1,904.01 17.25 0.91%
market minute promo

Celgene (NASDAQ: CELG)

92.00 3.88 (4.40%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $92.00 4.40%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $88.84
Previous Close $88.12
Daily Range $88.57 - $92.55
52-Week Range $66.85 - $96.50
Market Cap $73.6B
P/E Ratio 50.94
Dividend (Yield) $0.00 (0.0%)
Volume 7,967,340
Average Daily Volume 4,789,762
Current FY EPS $3.20

Sector

Healthcare

Industry

Drugs

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary

A Quick Look at Celgene Corporation's Drug Development Pipeline

Celgene's drug development pipeline is currently firing on all cylinders; but can it stay that way for long? Find out as we take a closer look at the experimental drugs which matter most to Celgene.

3 Stocks Reiterated As A Buy: PFE, MU, CELG

First Detailed Look at Celgene Crohn's Disease Pill Impresses

End Of The Year Events To Drive Some Of October's Beaten Up Biotech Companies

Phase II Data In Crohn's Disease For Celgene's Oral Antisense Therapy GED-0301 To Be Presented At UE

Phase II Data In Crohn's Disease For Celgene's Oral Antisense Therapy GED-0301 To Be Presented At UEG Week 2014

Benzinga Weekly Preview: Earnings Season Is In Full Swing

Cramer's Lightning Round - Ensco Is One Of The Worst Stocks I've Owned In My Life (10/17/14)

'Mad Money' Lightning Round: Lots of Ways to Win With Molson Coors

Agios (AGIO) Rises on Expansion of Phase I Study on AG-221 - Analyst Blog

VHT, BMY, UNH, CELG: Large Inflows Detected at ETF

See More CELG News...

CELG's Top Competitors

CELG $92.00 (4.40%)
Current stock: CELG
AMGN $137.51 (2.86%)
Current stock: AMGN
GILD $102.21 (1.45%)
Current stock: GILD
$0.00 (0.00%)
Current stock: